Shixin Zhou

Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.

Journal: Cell stem cell

Published: April 10, 2026

ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy.

ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy.

Journal: Protein & cell

Published: July 14, 2025

PERK and IRE1α promote exosome secretion via blocking lysosomal degradation of multiple vesicular body.

PERK and IRE1α promote exosome secretion via blocking lysosomal degradation of multiple vesicular body.

Journal: The Journal of biological chemistry

Published: June 09, 2025

iPSC-derived NK cells engineered with CD226 effectively control acute myeloid leukemia.

iPSC-derived NK cells engineered with CD226 effectively control acute myeloid leukemia.

Journal: Experimental hematology & oncology

Published: April 05, 2025

Manganese suppresses tumor growth through hyper-activating IRE1α.

Manganese suppresses tumor growth through hyper-activating IRE1α.

Journal: iScience

Published: December 26, 2024

Correction: pH-Responsive fluorescent graphene quantum dots for fluorescence-guided cancer surgery and diagnosis.

Correction: pH-Responsive fluorescent graphene quantum dots for fluorescence-guided cancer surgery and diagnosis.

Journal: Nanoscale

Published: February 19, 2024

Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses.

Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 17, 2023

Annotation of CD8+ T-cell function via ICAM-1 imaging identifies FAK inhibition as an adjuvant to augment the antitumor immunity of radiotherapy.

Annotation of CD8+ T-cell function via ICAM-1 imaging identifies FAK inhibition as an adjuvant to augment the antitumor immunity of radiotherapy.

Journal: Theranostics

Published: October 02, 2023

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells.

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells.

Journal: Journal of hematology & oncology

Published: February 06, 2023

Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production.

Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production.

Journal: Cell metabolism

Published: February 06, 2022

Author Correction: Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids.

Author Correction: Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids.

Journal: Nature biomedical engineering

Published: January 22, 2022

Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.

Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.

Journal: Journal of nanobiotechnology

Published: April 19, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026